Our findings fail to support a model wherein talin regulates the expression level of IKKβ to drive high levels of NF-kB signaling in oral carcinomas following treatment with cisplatin [45], [46]. This evidence concerns the gene NFKB1 and lip and oral cavity carcinoma.